Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 30 Jun 2024 15:57:10 +0200Thu, 21 Mar 2024 09:11:00 +0100Human medicines European public assessment report (EPAR): Dapagliflozin Viatris, dapagliflozin, Date of authorisation: 24/03/2023, Revision: 2, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/dapagliflozin-viatrisHuman medicines European public assessment report (EPAR): Dapagliflozin Viatris, dapagliflozin, Date of authorisation: 24/03/2023, Revision: 2, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/dapagliflozin-viatrisThu, 21 Mar 2024 09:11:00 +0100Human medicineDapagliflozin Viatris : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6006_en_2.pdfDapagliflozin Viatris : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6006_en_2.pdfThu, 18 Jan 2024 11:30:00 +0100Human medicine